The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Thermo Fisher Scientific Inc

NYSE: TMO
Last

(U.S.) $152.20

Today's change-0.96 -0.63%
Updated August 31 12:00 PM EDT. Delayed by at least 15 minutes.
 

Thermo Fisher Scientific Inc

NYSE: TMO
Last

(U.S.) $152.20

Today's change-0.96 -0.63%
Updated August 31 12:00 PM EDT. Delayed by at least 15 minutes.

Thermo Fisher Scientific Inc down (U.S.)$0.96

Thermo Fisher Scientific Inc is lower today, dropping (U.S.)$0.96 or 0.63% to (U.S.)$152.20. Over the last five days, shares have gained 0.62% and 7.30% year to date. Shares have outperformed the S&P 500 by 11.55% during the last year.

Key company metrics

  • Open(U.S.) $153.17
  • Previous close(U.S.) $153.16
  • High(U.S.) $153.40
  • Low(U.S.) $152.02
  • Bid / Ask(U.S.) $152.17 / (U.S.) $152.21
  • YTD % change+7.30%
  • Volume296,848
  • Average volume (10-day)1,232,393
  • Average volume (1-month)1,142,273
  • Average volume (3-month)1,357,343
  • 52-week range(U.S.) $117.10 to (U.S.) $160.68
  • Beta1.00
  • Trailing P/E30.41×
  • P/E 1 year forward18.79×
  • Forward PEG1.80×
  • Indicated annual dividend(U.S.) $0.60
  • Dividend yield0.39%
  • Trailing EPS(U.S.) $5.01
Updated August 31 12:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+11.38%

Based on its net profit margin of 11.38%, Thermo Fisher Scientific Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.67%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJul 02, 201607/02/2016Apr 02, 201604/02/2016Dec 31, 201512/31/2015Sep 26, 201509/26/2015
Revenue4,5354,2954,6534,123
Total other revenue--------
Total revenue4,5354,2954,6534,123
Gross profit2,0791,9582,1081,883
Total cost of revenue2,4572,3372,5442,240
Total operating expense3,8983,7773,9623,560
Selling / general / administrative1,2191,1841,1801,109
Research & development182177180172
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)39805840
Other operating expenses, total--------
Operating income638518690563
Interest income (expense), net non-operating-119-106-103-101
Gain (loss) on sale of assets--------
Other--------
Income before tax521423583468
Income after tax517402606477
Income tax, total421-24-9
Net income517402603476
Total adjustments to net income--------
Net income before extra. items517402606477
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items517402606477
Inc. avail. to common incl. extra. items517402603476
Diluted net income517402603476
Dilution adjustment--------
Diluted weighted average shares397399403402
Diluted EPS excluding extraordinary itemsvalue per share1.301.011.511.19
Dividends per sharevalue per share0.150.150.150.15
Diluted normalized EPSvalue per share1.401.201.621.25